Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-03-04

Clinical Trial Update: INST 0603C Patients With Unresectable/Metastatic Pancreatic Cancer Treated in the UNM Cancer

View source ↗

Summary

Clinical trial update for INST 0603C in unresectable/metastatic pancreatic cancer; study terminated with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • INST 0603C

Snippet

Sponsor: University of New Mexico | Conditions: Pancreatic Cancer | Status: TERMINATED | Results posted: 2015-03-04